U.S. Woman Gives Birth To First Known Baby With SARS-CoV-2 Antibodies

The 1st case of a baby born with SARS-CoV-2 antibodies was reported in the U.S. The woman had taken the 1st dosage of the Moderna mRNA vaccine at 36 weeks and 3 days of her pregnancy.

After 3 weeks, she gave birth to a healthy and full-term baby girl, and the baby’s blood sample taken shortly after birth showed the presence of COVID-19 antibodies.

Paul Gilbert and Chad Rudnick, Florida Atlantic College, United States, and co-authors of the paper stated that they had recorded the 1st case of a baby with SARS-CoV-2 IgG antibodies detectable in cord blood after immunizing the mother.

The mother, who has been breastfeeding the child, was administered the 2nd dosage of the vaccine according to the regular 28-day vaccination protocol timeline.

Asper the previous studies, it was less anticipated that the antibodies from COVID-recuperated mothers will pass on to their fetus through the placenta. However, the recent study infers the potential for protection and decrease in infection risk from COVID-19 with maternal vaccination. Gilber and Rudnick note that additional research is required to measure the antibody response in infants born to immunized mothers.

The doctors stated that the safety effectiveness in infants and the perfect timing of maternal vaccination stay to be unknown.

The doctors stated that they prompt various other investigators to develop maternity and breastfeeding registries and carry out effectiveness and safety research of the COVID-19 vaccines in pregnant and breastfeeding women and their children.

Source: Biotchnika – https://www.biotecnika.org/2021/03/first-baby-born-with-sars-cov-2-antibodies-us/